Study Protocol for the Artificial Intelligence-Driven Evaluation of Structural Heart Diseases Using Wearable Electrocardiogram (ID-SHD)
Preprint
Abstract
Introduction Portable devices capable of electrocardiogram (ECG) acquisition have the potential to enhance structural heart disease (SHD) management by enabling early detection through artificial intelligence-ECG (AI-ECG) algorithms. However, the performance of these AI algorithms for identifying SHD in a real-world screening setting is unknown. To address this gap, we aim to evaluate the validity of our wearable-adapted AI algorithm, which has been previously developed and validated for detecting SHD from single-lead portable ECGs in patients undergoing routine echocardiograms in the Yale New Haven Hospital (YNHH). Research Methods and Analysis This is the protocol for a cross-sectional study in the echocardiographic laboratories of YNHH. The study will enroll 585 patients referred for outpatient transthoracic echocardiogram (TTE) as part of their routine clinical care. Patients expressing interest in participating in the study will undergo a screening interview, followed by enrollment upon meeting eligibility criteria and providing informed consent. During their routine visit, patients will undergo a 1-lead ECG with two devices - one with an Apple Watch and the second with another portable 1-lead ECG device. With participant consent, these 1-lead ECG data will be linked to participant demographic and clinical data recorded in the YNHH electronic health records (EHR). The study will assess the performance of the AI-ECG algorithm in identifying SHD, including left ventricular systolic dysfunction (LVSD), valvular disease and severe left ventricular hypertrophy (LVH), by comparing the algorithm’s results with data obtained from TTE, which is the established gold standard for diagnosing SHD. Ethics and Dissemination All patient EHR data required for assessing eligibility and conducting the AI-ECG will be accessed through secure servers approved for protected health information. Data will be maintained on secure, encrypted servers for a minimum of five years after the publication of our findings in a peer-reviewed journal, and any unanticipated adverse events or risks will be reported by the principal investigator to the Yale Institutional Review Board, which has reviewed and approved this protocol (Protocol Number: 2000035532).Keywords
This publication has 24 references indexed in Scilit:
- Use of Smart Devices to Track Cardiovascular Health Goals in the United StatesJACC: Advances, 2023
- Detection of left ventricular systolic dysfunction from single-lead electrocardiography adapted for portable and wearable devicesnpj Digital Medicine, 2023
- Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020JAMA Network Open, 2023
- Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable DevicesJAMA Health Forum, 2022
- The Use of Wearable ECG Devices in the Clinical Setting: a ReviewCurrent Emergency and Hospital Medicine Reports, 2022
- Diagnosis and Evaluation of Hypertrophic CardiomyopathyJACC, 2022
- Harnessing protein folding neural networks for peptide–protein dockingNature Communications, 2022
- Wave of WearablesClinics In Laboratory Medicine, 2020
- Clinical Presentation, Spectrum of Disease, and Natural History2019
- Qualitative and quantitative evaluation of a new wearable device for ECG and respiratory Holter monitoringInternational Journal of Cardiology, 2018